European Union - Slovenian - EMA (European Medicines Agency)

sanofi pasteur msd, snc - prečiščeni proti davici toxoid, prečiščeni tetanus toxoid, prečiščeni oslovskemu kašlju toxoid, prečiščeni oslovskemu kašlju nitastih haemagglutinin, hepatitis b surface antigen, inaktivirano tipa 1 poliovirus (mahoney), inaktivirano tipa 2 poliovirus (mef 1), inaktivirano tip 3 poliovirus (saukett), haemophilus influenzae tip b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - to kombinirano cepivo je indicirano za osnovno in obnovitveno cepljenje otrok proti davici, tetanus, oslovski kašelj, hepatitis b, zaradi vseh znanih podtipov virusov, otroški ohromelosti in invazivne okužbe zaradi haemophilus influenzae tipa b.

European Union - Slovenian - EMA (European Medicines Agency)

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - hexyon (dtap-ipv-hb-hib) je indicirano za osnovno in obnovitveno cepljenje dojenčkov in malčkov iz šestih tednih starosti proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

European Union - Slovenian - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - infanrix hexa je indicirano za osnovno in obnovitveno cepljenje dojenčkov proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in bolezen, ki povzroča haemophilus influenzae tipa b.

European Union - Slovenian - EMA (European Medicines Agency)

mcm vaccine b.v. - davica toxoid, tetanus toxoid, bordetella oslovskemu kašlju antigenov: oslovskemu kašlju toxoid, nitastih haemagglutinin, pertactin, fimbriae vrste 2 in 3, hepatitis b surface antigen, proizvedene v kvas celice, poliovirus (inaktivirano): tip 1 (mahoney), tip 2 (mef-1), tip 3 (saukett), ki v chicagu celic/ haemophilus influenzae tipa b polysaccharide (polyribosylribitol fosfat) konjugiran na meningococcal beljakovin. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - cepiva - vaxelis (dtap-hb-ipv-hib) je indicirano za osnovno in obnovitveno cepljenje pri dojenčkih in malčkih od starosti 6 tednov, proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba zdravila vaxelis mora biti v skladu z uradnimi priporočili.

European Union - Slovenian - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - davica toxoid, tetanus toxoid, inaktivirano bordetella oslovskemu kašlju, hepatitisu b površinski antigen (rdna), haemophilus influenzae tip b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; diphtheria - cepiva - quintanrix je indicirano za primarni imunizaciji dojenčkov (v prvem letu življenja) proti davici, tetanus, oslovski kašelj, hepatitis b in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b in za dvig imunizacije otrok med na drugo leto življenja. uporaba quintanrix je treba določiti na podlagi uradnih priporočil.

Slovenia - Slovenian - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - železo - raztopina za injiciranje/infundiranje - železo 20 mg / 1 ml - zdravila z železom za parenteralno uporabo

European Union - Slovenian - EMA (European Medicines Agency)

ceva santé animale - inaktivirana cepiva coxiella burnetii, sev devet milj - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

European Union - Slovenian - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - cepiva - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. uporaba shingrix mora biti v skladu z uradnimi priporočili.